Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02204800 · ClinicalTrials.gov registry record
Active Surveillance of the Small Renal Mass
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 4
- Enrollment target
NCT02204800 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 4 participants.
The verdict
NCT02204800 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 4 participants
- Enrollment target
Study Summary
Active surveillance in kidney cancer involves closely observing the tumor with periodic imaging studies rather than immediately proceeding to an invasive treatment. This does not mean that the tumor is ignored or that future treatment is not necessary, rather it means the tumor does not require treatment at this time. On active surveillance, a tumor is closely monitored without treatment, however if the tumor changes and reaches a predefined threshold that your physician no longer considers safe, your physician will strongly encourage treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-12 |
| Est. Completion | 2020-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02204800
The ClinicalTrials.gov registry entry for NCT02204800 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02204800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02204800 about?
NCT02204800 is a clinical study titled "Active Surveillance of the Small Renal Mass". Active surveillance in kidney cancer involves closely observing the tumor with periodic imaging studies rather than immediately proceeding to an invasive treatment. This does not mean that the tumor is ignored or that future treatment is not necessary, rather it means the tumor does not require trea...
What is the current status of trial NCT02204800?
This trial is currently completed. The enrollment target is 4 participants. The study started on 2014-12. Estimated completion is 2020-08-31.
Who is sponsoring clinical trial NCT02204800?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.